Latest articles by Dr Mike Tubbs
-
Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
-
Vertex Pharmaceuticals is a rare opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
-
Investment opportunities in supporting an ageing population
Ageing populations have prompted fruitful research in sectors ranging from pharmaceuticals and medical equipment to glasses and hearing aids
-
Singapore Technologies Engineering shows strong growth
Singapore Technologies Engineering offers diversification, improving profitability and income
-
4Imprint makes a strong impression – should you buy?
4Imprint, a specialist in marketing promotional products, is the leader in a fragmented field
-
Investing in pharmaceutical companies? The pipeline is key
A strong pipeline is all-important for pharmaceutical companies. We highlight the most interesting candidates.
-
How Finseta is cashing in on currencies
Finseta has established a foothold in the upper echelons of the market for international payments. Should you invest?
-
Relx outperforms: should you buy this FTSE 100 success story?
Relx, a fast-growing risk management and analytics group is benefiting from artificial intelligence
-
8 dividend super aristocrats to look out for
Share Tips Consider these dividend super aristocrats that have increased their payout for up to 60 years in a row.
Share Tips -
Diploma: a blue-chip set for strong growth
Diploma, whose niche products include seals and fasteners, serves an array of growth markets. Should you invest?
-
Why you should consider founder-led firms for your portfolio
Founder-led firms tend to outperform. Dr Mike Tubbs explains why and surveys the world’s equity markets to gauge which ones currently look the most appealing
-
Time to tuck in to McDonald’s
McDonald’s, the world’s largest restaurant chain, is a highly profitable business with plenty of room to grow.
-
9 stocks to buy for solid dividends
Dr Mike Tubbs singles out nine stocks poised to deliver strong earnings growth and solid dividends.
-
Buy stocks with wide moats to protect your profits
Tips Companies with wide "moats" – attributes that give them an enduring competitive advantage – tend to thrive over the long term. Dr Mike Tubbs explains how to identify them and how to invest in them.
Tips -
Why this biotech company has years of growth ahead
Analysis Zimmer Biomet, a leader in the worldwide market for hip and knee joints, enjoys a competitive advantage and has years of growth ahead, says Dr Mike Tubbs.
Analysis -
How to find the market’s “multi-bagger” stocks
Advice The success of major indices is based on a handful of spectacular performers. Dr Mike Tubbs outlines the key characteristics of shares capable of rising tenfold or more – and suggests where to start looking
Advice -
A UK-listed multinational engineer with strong growth and rising dividends
Tips Spirax-Sarco is a world-leading engineer making consistent progress in three niche markets, with an order book at an all-time high.
Tips -
Investing in drugmakers: uncommon profits from curing rare diseases
Cover Story Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors because of government incentives, says Dr Mike Tubbs.
Cover Story -
Raytheon Technologies: a safe stock for an unsafe world
Tips Defence spending is set to soar – that should be good news for aerospace heavyweight Raytheon Technologies.
Tips -
Veterinary medicine stocks: the firms keeping your pet healthy
Cover Story Pet ownership has grown due to the pandemic. That’s good news for animal health stocks, says Dr Mike Tubbs
Cover Story -
Adobe: a growth stock with a wide moat
Tips Adobe already dominates the creative industries – now it’s expanding into ecommerce
Tips -
The best vaccine-makers’ stocks to buy now
Cover Story The rapid development of Covid-19 vaccines has already saved many lives and made huge profits for a few pharmaceutical firms. Investors should keep an eye on other products in their pipelines, says Dr Mike Tubbs.
Cover Story -
Molten Ventures: invest in digital technology with this venture capitalist
Tips Molten Ventures offers investors access to fast-growing unlisted companies across Europe
Tips -
The nifty nine: a portfolio of stocks to buy and hold forever
Cover Story A diverse range of stocks you can buy and keep forever should be a core part of any equity portfolio, says Dr Mike Tubbs. He selects his nine favourites from sectors ranging from agriculture to scientific instruments.
Cover Story
